Natick-based Boston Scientific Corp. has been given the go-ahead from the U.S. Food and Drug Administration to market its FilterWire EX Embolic Protection System to treat saphenous vein graft (SVG) ...
SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. on Monday said two studies showed a composite 98.1% procedural success rate by its second-generation FilterWire EZ Embolic Protection System in ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
BOSTON, MA—Those who were hoping that PROTECTED TAVR would provide a clear-cut result and bring closure to the question of whether cerebral embolic protection (CEP) reduces stroke in patients ...
Emboline has secured $20 million for its embolic protection system, designed to minimize stroke risk associated with transcatheter aortic valve replacement procedures. The Santa Cruz, CA-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results